Global threat– Multi-drug resistant pathogens

Next to malaria and AIDS, tuberculosis is the world's most widespread infectious disease. As well, in sepsis or in immune compromised patients with pneumonia, a quick diagnosis of the pathogen and its potential resistance to antibiotics is a requirement for optimum treatment. The number of multi-drug resistant pathogens is increasing, and not only hospital pathogens such as MRSA, but a new generation of antibiotic-resistant bacteria (e.g. carbapenemase producers) pose a threat and complicate treatment.

Modern infection diagnosis requires non-invasive and patient-friendly solutions that detect pathogens and their resistance potential quickly, inexpensively and on-site.